Chemotherapy induced peripheral neuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with malignant tumors through pathology. (2) Peripheral neuropathy occurs during or after chemotherapy (chemotherapy regimen is based on paclitaxel or platinum based chemotherapy) and the peripheral neurotoxicity is classified as I-III. (3) Meets the diagnostic criteria for spleen kidney deficiency and qi blood deficiency in traditional Chinese medicine. (4) Age range: 18-80 years old. (5) Patients with complete medical records for initial and follow-up visits.
Exclusion criteria
Exclusion criteria: (1) Patients with only one medical visit record. (2) Peripheral neuropathy caused by electrolyte disorder other systemic diseases (such as severe diabetes) poisoning infection radiotherapy etc. (3) Individuals with sensory disorders due to brain metastases intracranial hemorrhage etc. (4) During the treatment period medication and non pharmacological therapies for peripheral neuropathy caused by chemotherapy were received. (5) Explicitly reject the use of medical record data for researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quantitative Grading Table of Traditional Chinese Medicine Symptoms;EORTC QLQ-CIPN20 scale; | — |
Countries
China
Contacts
Xiyuan Hospital Chinese Academy of Traditional Chinese Medicine